title: Increased cellular distribution of vimentin and ret in the cingulum of rat offspring after developmental exposure to decabromodiphenyl ether or 1,2,5,6,9,10-hexabromocyclododecane.
abstract: To determine effects of developmental exposure to brominated flame retardants (BFRs), weak thyroid hormone disruptors, on white matter development, white matter-specific global gene expression analysis was performed using microdissection techniques and microarrays in male rats exposed maternally to decabromodiphenyl ether (DBDE), one of the representative BFRs, at 10, 100 or 1000 ppm. Based on previous gene expression profiles of developmental hypothyroidism and DBDE-exposed cases, vimentin(+) immature astrocytes and ret proto-oncogene (Ret)(+) oligodendrocytes were immunohistochemically examined after developmental exposure to representative BFRs, i.e., DBDE, 1,2,5,6,9,10-hexabromocyclododecane (HBCD; 100, 1000 or 10,000 ppm) and tetrabromobisphenol A (TBBPA; 100, 1000 or 10,000 ppm). Vimentin(+) and Ret(+) cell populations increased at ≥ 100 ppm and ≥ 10 ppm DBDE, respectively. Vimentin(+) and Ret(+) cells increased at ≥ 1000 ppm HBCD, with no effect of TBBPA. The highest dose of DBDE and HBCD revealed subtle fluctuations in serum thyroid-related hormone concentrations. Thus, DBDE and HBCD may exert direct effects on glial cell development at ≥ middle doses. At high doses, hypothyroidism may additionally be an inducing mechanism, although its contribution is rather minor.
authors.affiliation: Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Fujimoto
authors.forename: Gye-Hyeong
authors.initials: GH
authors.lastname: Woo
authors.forename: Reiko
authors.initials: R
authors.lastname: Morita
authors.forename: Megu
authors.initials: M
authors.lastname: Itahashi
authors.forename: Hirotoshi
authors.initials: H
authors.lastname: Akane
authors.forename: Akiyoshi
authors.initials: A
authors.lastname: Nishikawa
authors.forename: Makoto
authors.initials: M
authors.lastname: Shibutani
keywords: BFRs; Ret; glial development; hypothyroidism; rat; vimentin
references.citation: Nat Rev Neurosci. 2008 Jun;9(6):437-52
references.pmid: 18478032
references.citation: Reprod Toxicol. 2010 Jul;29(4):407-14
references.pmid: 20347957
references.citation: Cancer Sci. 2009 Apr;100(4):617-25
references.pmid: 19298605
references.citation: Toxicol Appl Pharmacol. 1982 Mar 30;63(1):133-41
references.pmid: 7071868
references.citation: Reprod Toxicol. 2011 Jan;31(1):86-94
references.pmid: 20851758
references.citation: Toxicol Sci. 2006 Jul;92(1):157-73
references.pmid: 16601080
references.citation: Reprod Toxicol. 2004 Jan-Feb;18(1):23-33
references.pmid: 15013061
references.citation: Biochem Biophys Res Commun. 2004 May 21;318(1):204-12
references.pmid: 15110774
references.citation: Reprod Toxicol. 2012 Aug;34(1):93-100
references.pmid: 22504374
references.citation: Environ Health Perspect. 2000 Jun;108 Suppl 3:433-8
references.pmid: 10852841
references.citation: EMBO J. 2000 Aug 1;19(15):4056-63
references.pmid: 10921886
references.citation: J Clin Invest. 2003 Apr;111(7):1073-82
references.pmid: 12671057
references.citation: J Toxicol Environ Health A. 2009;72(21-22):1296-303
references.pmid: 20077200
references.citation: Chemosphere. 2002 Feb;46(5):583-624
references.pmid: 11999784
references.citation: Lab Invest. 2000 Feb;80(2):199-208
references.pmid: 10701689
references.citation: Neurotoxicol Teratol. 2007 Jul-Aug;29(4):511-20
references.pmid: 17482428
references.citation: J Vet Med Sci. 2010 Feb;72(2):187-95
references.pmid: 19942813
references.citation: Neuroscience. 1993 May;54(1):15-36
references.pmid: 8515840
references.citation: Environ Int. 2003 Sep;29(6):841-53
references.pmid: 12850100
references.citation: Neurotoxicology. 2007 Jan;28(1):136-42
references.pmid: 17030062
references.citation: Arch Toxicol. 2012 Sep;86(9):1431-42
references.pmid: 22415764
references.citation: Endocrinology. 2004 Nov;145(11):5013-20
references.pmid: 15256491
references.citation: Endocrinology. 2008 Aug;149(8):4001-8
references.pmid: 18420739
references.citation: Mol Psychiatry. 2006 Apr;11(4):361-71
references.pmid: 16446739
references.citation: Toxicol Lett. 2005 Jan 15;155(1):127-33
references.pmid: 15585367
references.citation: J Neurosci Res. 1997 Dec 1;50(5):713-20
references.pmid: 9418959
references.citation: Environ Health Perspect. 2011 Feb;119(2):168-75
references.pmid: 20870570
references.citation: Neurotoxicol Teratol. 1991 May-Jun;13(3):317-22
references.pmid: 1886541
references.citation: Int J Dev Neurosci. 2009 Aug;27(5):423-9
references.pmid: 19465108
references.citation: Toxicology. 2011 Apr 28;283(1):49-54
references.pmid: 21345361
references.citation: Toxicology. 2008 Apr 3;246(1):45-54
references.pmid: 18295390
references.citation: Reprod Toxicol. 2009 Dec;28(4):456-67
references.pmid: 19577631
references.citation: Neurochem Int. 2003 Sep-Oct;43(4-5):533-42
references.pmid: 12742101
references.citation: J Cell Sci. 2003 Oct 1;116(Pt 19):3855-62
references.pmid: 12953054
references.citation: Environ Health Perspect. 2004 Jan;112(1):9-17
references.pmid: 14698924
references.citation: J Cell Biol. 2001 Apr 16;153(2):295-305
references.pmid: 11309411
references.citation: Reprod Toxicol. 2009 Nov;28(3):297-307
references.pmid: 19397998
references.citation: Glia. 2001 Jun;34(4):253-66
references.pmid: 11360298
references.citation: Environ Toxicol Pharmacol. 2006 May;21(3):317-22
references.pmid: 21783674